Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2018 Financial Results

UPDATE: Galmed Pharma (GLMD) Reports Q2 Loss of $0.17

August 2, 2018 7:47 AM EDT

(Updated - August 2, 2018 7:48 AM EDT)

Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS Loss of $0.17, versus ($0.16) reported last year. Revenue for the quarter came in at $270 thousand versus the consensus estimate of $270 thousand.

Financial Summary - First Quarter 2018 vs. First Quarter 2017:

Cash and cash equivalents and marketable securities totaled $94.1 million as of June 30, 2018, compared to $19.0 million at December 31, 2017. The increase is mainly... More